1,004
Views
6
CrossRef citations to date
0
Altmetric
Short Report

Targeting the gram-negative bacteria peptidoglycan synthase MraY as a new approach for monoclonal antibody anti-bacterial activity

, , , , , & show all
Pages 2086-2091 | Received 09 Jan 2017, Accepted 30 May 2017, Published online: 12 Jul 2017

References

  • Bajaj P, Singh NS, Virdi JS. Escherichia coli beta-Lactamases: What really matters. Front Microbiol 2016; 7:417; PMID:27065978; https://doi.org/10.3389/fmicb.2016.00417
  • Vila J, Saez-Lopez E, Johnson JR, Romling U, Dobrindt U, Canton R, et al. Escherichia coli: An old friend with new tidings. FEMS Microbiology Reviews 2016; 40:437-463
  • Goure J, Pastor A, Faudry E, Chabert J, Dessen A, Attree I. The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes. Infect Immun 2004; 72:4741-50; PMID:15271936; https://doi.org/10.1128/IAI.72.8.4741-4750.2004
  • Horn MP, Zuercher AW, Imboden MA, Rudolf MP, Lazar H, Wu H, Hoiby N, Fas SC, Lang AB. Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11. Antimicrob Agents Chemother 2010; 54:2338-44; PMID:20308370; https://doi.org/10.1128/AAC.01142-09
  • Tkaczyk C, Hua L, Varkey R, Shi Y, Dettinger L, Woods R, Barnes A, MacGill RS, Wilson S, Chowdhury P, et al. Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency. Clin Vaccine Immunol 2012; 19:377-85; PMID:22237895; https://doi.org/10.1128/CVI.05589-11
  • Bugg TD, Rodolis MT, Mihalyi A, Jamshidi S. Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage varphiX174 lysis protein E, and cationic antibacterial peptides. Bioorg Med Chem 2016; 24:6340-47; PMID:27021004; https://doi.org/10.1016/j.bmc.2016.03.018
  • Shapiro AB, Jahic H, Gao N, Hajec L, Rivin O. A high-throughput, homogeneous, fluorescence resonance energy transfer-based assay for phospho-N-acetylmuramoyl-pentapeptide translocase (MraY). J Biomol Screen 2012; 17:662-72; PMID:22337656; https://doi.org/10.1177/1087057112436885
  • Chung BC, Mashalidis EH, Tanino T, Kim M, Matsuda A, Hong J, Ichikawa S, Lee SY. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis. Nature 2016; 533:557-60; PMID:27088606; https://doi.org/10.1038/nature17636
  • Chung BC, Zhao J, Gillespie RA, Kwon DY, Guan Z, Hong J, Zhou P, Lee SY. Crystal structure of MraY, an essential membrane enzyme for bacterial cell wall synthesis. Science 2013; 341:1012-6; PMID:23990562; https://doi.org/10.1126/science.1236501
  • Koppermann S, Ducho C. Natural products at work: Structural insights into inhibition of the bacterial membrane protein MraY. Angewandte Chemie 2016; 55:11722-4; PMID:27511599; https://doi.org/10.1002/anie.201606396
  • Wang H, Zhu T, Yu S, Liu H, Wang X, Chen L, Si W, Pang H, Liu S. A novel B cell epitope in cold-shock DEAD-box protein A from mycobacterium tuberculosis. Res Vet Sci 2013; 94:406-12; PMID:23261158; https://doi.org/10.1016/j.rvsc.2012.11.013
  • Franz E, Veenman C, van Hoek AH, de Roda Husman A, Blaak H. Pathogenic escherichia coli producing extended-spectrum beta-lactamases isolated from surface water and wastewater. Sci Rep 2015; 5:14372; PMID:26399418; https://doi.org/10.1038/srep14372
  • Irani V, Guy AJ, Andrew D, Beeson JG, Ramsland PA, Richards JS. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases. Mol Immunol 2015; 67:171-82; PMID:25900877; https://doi.org/10.1016/j.molimm.2015.03.255
  • Warrener P, Varkey R, Bonnell JC, DiGiandomenico A, Camara M, Cook K, Peng L, Zha J, Chowdury P, Sellman B, et al. A novel anti-pcrv antibody providing enhanced protection against pseudomonas aeruginosa in multiple animal infection models. Antimicrob Agents Chemother 2014; 58:4384-91; PMID:24841258; https://doi.org/10.1128/AAC.02643-14
  • Poolman JT, Wacker M. Extraintestinal pathogenic escherichia coli, a common human pathogen: Challenges for vaccine development and progress in the field. J Infect Dis 2016; 213:6-13; PMID:26333944; https://doi.org/10.1093/infdis/jiv429
  • Szijártó V, Guachalla LM, Visram ZC, Hartl K, Varga C, Mirkina I, Zmajkovic J, Badarau A, Zauner G, Pleban C, et al. Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice. Antimicrob Agents Chemother 2015; 59:3109-16; PMID:25779571; https://doi.org/10.1128/AAC.04494-14

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.